Buchumschlag

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Lucie Simonis, Lorenz Balcar, Anna Schedlbauer, Marta Tonon, Nikolaj Torp, Valeria Santori, Katharina Stopfer, Jan Embacher, Christian Sebesta, Leonie Hafner, Benedikt Silvester Hofer, Nina Dominik, Georg Kramer, Paul Thöne, Michael Trauner, Aleksander Krag, Salvatore Piano, Mattias Mandorfer, Thomas Reiberger, Georg Semmler
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Authors' Reply
von: Lucie Simonis, et al.
Veröffentlicht: (2025)

Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis
von: Nina Dominik, et al.
Veröffentlicht: (2025)

Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2026)

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
von: Mathias Jachs, et al.
Veröffentlicht: (2025)

Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure
von: Vlad Taru, et al.
Veröffentlicht: (2025)

Personalised Long‐Term Albumin Treatment Based on Three‐Month Ascites Response in Patients With Decompensated Cirrhosis
von: Enrico Pompili, et al.
Veröffentlicht: (2026)

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
von: Lukas Hartl, et al.
Veröffentlicht: (2024)

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
von: Nina Dominik, et al.
Veröffentlicht: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
von: Nina Dominik, et al.
Veröffentlicht: (2024)

GDF ‐15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2026)

Prognostication of Liver Disease Patients via the WFUMB ‘Rule‐of‐4’ Algorithm Using SSI ‐ 2D ‐ SWE ‐Based Liver Stiffness Measurement
von: Christian Sebesta, et al.
Veröffentlicht: (2026)

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease
von: Benedikt Simbrunner, et al.
Veröffentlicht: (2025)

Research Communication: The Cumulated Spontaneous Portosystemic Shunts ( SPSS ) Area Decreases After TIPS and Impacts on Prognosis
von: Marlene Hintersteininger, et al.
Veröffentlicht: (2025)

GDF ‐15 in Cirrhosis: Signal, Guide or Both?—Authors' Reply
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2026)

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2024)

Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2024)

A Rare, Atypical Presentation of Decompensated Cirrhosis: Isolated Transudative Hepatic Chylothorax Without Ascites
von: Michael Yulong Wu, et al.
Veröffentlicht: (2025)

Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice—Authors' Reply
von: Nikolaj Torp, et al.
Veröffentlicht: (2025)

Editorial: Two Common Risks, One Greater Harm—Diabetes and Alcohol in Steatotic Liver Disease
von: Stine Johansen, et al.
Veröffentlicht: (2026)

Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma
von: Katharina Pomej, et al.
Veröffentlicht: (2024)

Home Management of Refractory Ascites in Decompensated Cirrhosis With Long‐Term Abdominal Drains, a Pilot Study
von: Jeyamani Ramachandran, et al.
Veröffentlicht: (2025)

Radiomics‐Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT Scans
von: Celine Sin, et al.
Veröffentlicht: (2026)

MRI-derived quantification of hepatic vessel-to-volume ratios in chronic liver disease using a deep learning approach
von: Herold, Alexander, et al.
Veröffentlicht: (2025)

Decompensated or Acute Heart Failure
von: Enrique Fairman
Veröffentlicht: (2016)

Refractory Ascites in Patients With Cirrhosis
von: Madhumita Premkumar
Veröffentlicht: (2025)

Patient Plasma‐Induced Neutrophil Dysfunction Is Associated With Infection Risk and Mortality in Patients With Acute Decompensation of Cirrhosis
von: Supachaya Sriphoosanaphan, et al.
Veröffentlicht: (2025)

Acute Abdomen in Pregnancy due to Idiopathic Chylous Ascites
von: Claudia Epelde, et al.
Veröffentlicht: (2024)

TIPS to Treat Chylous Ascites due to Cirrhosis
von: Muhammad Amir, et al.
Veröffentlicht: (2025)

Serum Villin‐1—A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation
von: David Tornai, et al.
Veröffentlicht: (2025)

Response to “Reflections on the Study of Physiological Determinants in Cirrhosis With Ascites”
von: Nikhilesh R. Mazumder, et al.
Veröffentlicht: (2024)

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
von: Lukas Burghart, et al.
Veröffentlicht: (2024)

Nurse‐Led Clinic for Patients With Decompensated Liver Cirrhosis
von: Elsebeth E. Kelstrup, et al.
Veröffentlicht: (2026)

The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study
von: David J. M. Bauer, et al.
Veröffentlicht: (2024)

Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death
von: Caroline Schwarz, et al.
Veröffentlicht: (2025)

Editorial: Diabetes Management in Cirrhosis—The Window of Opportunity Before Decompensation
von: Thanawin Pramotedham, et al.
Veröffentlicht: (2026)

Predictive Value of Coagulation Factor VIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis
von: Siyu Jiang, et al.
Veröffentlicht: (2025)

Leitfaden Interview BCT in Forest Supply Chains
von: Stopfer, Lukas
Veröffentlicht: (2023)

Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis
von: Magdalini Adamantou, et al.
Veröffentlicht: (2025)

Clinical Impact and Therapeutic Management of Diabetes Mellitus in Patients With Decompensated Cirrhosis
von: Chiara Lisi, et al.
Veröffentlicht: (2026)

Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated Cirrhosis
von: Susan E. Fischer, et al.
Veröffentlicht: (2026)